Chattanooga shooter was on SSRI's

Gee… what shocker. According to reports, last Thursday twenty-four-year-old Muhammad Youssef Abdulazeez opened fire at a Chattanooga army recruiting center, injuring a police officer. Then he opened fire at a navy recruiting center about five miles away, killing four servicemen and wounding another three, one of whom later passed away. All told, five people lost their lives before the Abdulazeez was shot and killed by police.

By now, it shouldn’t surprise anyone much that the media is reporting Abdulazeez was depressed and taking medications for it, medications which he frequently started and stopped.  Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), come with FDA-mandated black box warnings on the labels to inform users, “about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment.” Cited from

According to the FDA:

“Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders.”

Confirming this story is Greta van Susteren at  or see

Then there is this one: SPARKS, Nev. (AP) — A Nevada seventh-grader who went on a deadly shooting rampage at his school nearly seven months ago had been teased at school and was taking a prescription antidepressant, police said Tuesday. Jose Reyes, 12, opened fire Oct. 21 at Sparks Middle School, killing a teacher and wounding two classmates before committing suicide. He brought the semi-automatic handgun from home. At a news conference Tuesday, Sparks Police Chief Brian Allen released key findings from an investigation into the shootings. Among them, he said, was that Reyes had told a psychotherapist that other students made fun of him and called him names.